McLean Hospital: Novel Treatment Using Patient's Own Cells Opens New Possibilities to Treat Parkinson's Disease
May 15, 2020
May 15, 2020
BELMONT, Massachusetts, May 15 -- McLean Hospital issued the following news release:
Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) in the most recent issue of The New England Journal of Medicine.
PD is the second most common degenerative dise . . .
Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) in the most recent issue of The New England Journal of Medicine.
PD is the second most common degenerative dise . . .